Elevated HSF-1 levels drive metastasis by suppressing antimetastatic gene expression and activating pro-metastatic signaling pathways, including the upregulation of metastasis-associated protein 1 (MTA-1), which interferes with oestrogen-mediated tumor suppression. The gene discussed is MTA1; the disease is neoplasm.